Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer
JCO Precis Oncol
.
2022 Sep:6:e2100516.
doi: 10.1200/PO.21.00516.
Authors
Edward D Esplin
1
,
Sarah M Nielsen
1
,
Sara L Bristow
1
,
Judy E Garber
2
,
Heather Hampel
3
,
Huma Q Rana
2
,
N Jewel Samadder
4
5
6
,
Neal D Shore
7
,
Robert L Nussbaum
1
Affiliations
1
Invitae, San Francisco, CA.
2
Dana Farber Cancer Institute, Boston, MA.
3
Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutic Research, City of Hope National Cancer Center, Duarte, CA.
4
Center for Individualized Medicine, Mayo Clinic, Phoenix, AZ.
5
Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Phoenix, AZ.
6
Department of Clinical Genomics, Mayo Clinic, Phoenix, AZ.
7
Carolina Urologic Research Center, Myrtle Beach, SC.
PMID:
36108258
PMCID:
PMC9489188
DOI:
10.1200/PO.21.00516
No abstract available
MeSH terms
Genetic Testing
Germ Cells
Humans
Neoplastic Syndromes, Hereditary* / diagnosis